Eyes with moderately severe to severe baseline diabetic retinopathy without prior panretinal photocoagulation experienced more rapid improvements from ranibizumab treatment compared with eyes with more mild or severe diabetic retinopathy, according to a presenter at the virtual Association for Research in Vision and Ophthalmology meeting.
“Eyes with moderately severe to severe NPDR at baseline achieved a two or more step improvement in diabetic retinopathy over time. These findings support treating eyes with moderately severe to severe NPDR before they progress to PDR,” Mitchell
Uncategorized